180 related articles for article (PubMed ID: 37916396)
1. SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism.
Mayr F; Kruse V; Fuhrmann DC; Wolf S; Löber J; Alsouri S; Paglilla N; Lee K; Chapuy B; Brüne B; Zenz T; Häupl B; Oellerich T; Engelke M
Haematologica; 2024 May; 109(5):1445-1459. PubMed ID: 37916396
[TBL] [Abstract][Full Text] [Related]
2. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival.
Pal Singh S; de Bruijn MJW; Velaso Gago da Graça C; Corneth OBJ; Rip J; Stadhouders R; Meijers RWJ; Schurmans S; Kerr WG; Ter Burg J; Eldering E; Langerak AW; Pillai SY; Hendriks RW
J Immunol; 2020 Jan; 204(2):360-374. PubMed ID: 31836657
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survival.
Corso J; Pan KT; Walter R; Doebele C; Mohr S; Bohnenberger H; Ströbel P; Lenz C; Slabicki M; Hüllein J; Comoglio F; Rieger MA; Zenz T; Wienands J; Engelke M; Serve H; Urlaub H; Oellerich T
Proc Natl Acad Sci U S A; 2016 May; 113(20):5688-93. PubMed ID: 27155012
[TBL] [Abstract][Full Text] [Related]
5. The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of Fc gammaRIIB in B cells under negative signaling.
Muraille E; Bruhns P; Pesesse X; Daëron M; Erneux C
Immunol Lett; 2000 Apr; 72(1):7-15. PubMed ID: 10789675
[TBL] [Abstract][Full Text] [Related]
6. HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling.
Walter R; Pan KT; Doebele C; Comoglio F; Tomska K; Bohnenberger H; Young RM; Jacobs L; Keller U; Bönig H; Engelke M; Rosenwald A; Urlaub H; Staudt LM; Serve H; Zenz T; Oellerich T
Blood; 2017 Feb; 129(5):598-608. PubMed ID: 28064214
[TBL] [Abstract][Full Text] [Related]
7. The SH2 domain-containing inositol 5'-phosphatase (SHIP) recruits the p85 subunit of phosphoinositide 3-kinase during FcgammaRIIb1-mediated inhibition of B cell receptor signaling.
Gupta N; Scharenberg AM; Fruman DA; Cantley LC; Kinet JP; Long EO
J Biol Chem; 1999 Mar; 274(11):7489-94. PubMed ID: 10066815
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.
Fuhler GM; Brooks R; Toms B; Iyer S; Gengo EA; Park MY; Gumbleton M; Viernes DR; Chisholm JD; Kerr WG
Mol Med; 2012 Feb; 18(1):65-75. PubMed ID: 22033675
[TBL] [Abstract][Full Text] [Related]
9. IRTKS Promotes Insulin Signaling Transduction through Inhibiting SHIP2 Phosphatase Activity.
Wu C; Cui X; Huang L; Shang X; Wu B; Wang N; He K; Han Z
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212584
[TBL] [Abstract][Full Text] [Related]
10. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
Giuriato S; Pesesse X; Bodin S; Sasaki T; Viala C; Marion E; Penninger J; Schurmans S; Erneux C; Payrastre B
Biochem J; 2003 Nov; 376(Pt 1):199-207. PubMed ID: 12885297
[TBL] [Abstract][Full Text] [Related]
11. The SH2 domains of inositol polyphosphate 5-phosphatases SHIP1 and SHIP2 have similar ligand specificity but different binding kinetics.
Zhang Y; Wavreille AS; Kunys AR; Pei D
Biochemistry; 2009 Nov; 48(46):11075-83. PubMed ID: 19839650
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells.
Fujii Y; Murata-Kamiya N; Hatakeyama M
Cancer Sci; 2020 May; 111(5):1596-1606. PubMed ID: 32198795
[TBL] [Abstract][Full Text] [Related]
13. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
Nakamura K; Brauweiler A; Cambier JC
J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
[TBL] [Abstract][Full Text] [Related]
14. The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are coexpressed in human T lymphocytes.
Bruyns C; Pesesse X; Moreau C; Blero D; Erneux C
Biol Chem; 1999; 380(7-8):969-74. PubMed ID: 10494849
[TBL] [Abstract][Full Text] [Related]
15. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.
Pesesse X; Moreau C; Drayer AL; Woscholski R; Parker P; Erneux C
FEBS Lett; 1998 Oct; 437(3):301-3. PubMed ID: 9824312
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase.
Ingham RJ; Okada H; Dang-Lawson M; Dinglasan J; van Der Geer P; Kurosaki T; Gold MR
J Immunol; 1999 Dec; 163(11):5891-5. PubMed ID: 10570274
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
18. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.
Erneux C; Edimo WE; Deneubourg L; Pirson I
J Cell Biochem; 2011 Sep; 112(9):2203-9. PubMed ID: 21503961
[TBL] [Abstract][Full Text] [Related]
19. The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2.
Batty IH; van der Kaay J; Gray A; Telfer JF; Dixon MJ; Downes CP
Biochem J; 2007 Oct; 407(2):255-66. PubMed ID: 17672824
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of SHIP2 SH2 domain and its interaction with a phosphotyrosine peptide from c-MET.
Wang Z; Nie Y; Zhang K; Xu H; Ramelot TA; Kennedy MA; Liu M; Zhu J; Yang Y
Arch Biochem Biophys; 2018 Oct; 656():31-37. PubMed ID: 30165040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]